[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Neural Therapeutics Inc. (NURL.CN)

Neural Therapeutics Inc. (NURL.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])

Fundamentals

See More
  • Market Capitalization, $K 2,538
  • Shares Outstanding, K 169,201
  • Annual Sales, $ 0 K
  • Annual Income, $ -1,026 K
  • EBIT $ N/A
  • EBITDA $ N/A
  • 60-Month Beta N/A
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 3.89
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm -0.01
  • Most Recent Earnings $0.00 on 03/25/26
  • Next Earnings Date N/A
  • Annual Dividend & Yield (Fwd) N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sector N/A
  • INDUSTRY GROUPING:

    SIC-2834 Pharmaceutical Preparations

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.0100 +50.00%
on 06/17/26
0.0200 -25.00%
on 06/04/26
unch (unch)
since 05/22/26
3-Month
0.0100 +50.00%
on 06/17/26
0.0200 -25.00%
on 06/04/26
unch (unch)
since 03/24/26
52-Week
0.0100 +50.00%
on 06/17/26
0.0350 -57.14%
on 11/12/25
-0.0150 (-50.00%)
since 06/24/25

Most Recent Stories

More News
Neural Therapeutics Inc. Announces Transition to Semi-Annual Financial Reporting

Toronto, Ontario--(Newsfile Corp. - June 19, 2026) - Neural Therapeutics Inc. (CSE: NURL) (FSE: HANF) ("Neural" or the "Company") announces that it has elected to voluntarily adopt semi-annual financial...

NURL.CN : 0.0150 (unch)
Neural Therapeutics Announces AGSM Results, CFO Appointment and Welcomes Positive Developments in the German Cannabis Market

Toronto, Ontario--(Newsfile Corp. - June 12, 2026) - Neural Therapeutics Inc. (CSE: NURL) (FSE: HANF) ("Neural" or the "Company") is pleased to announce the results of its annual general and special meeting...

NURL.CN : 0.0150 (unch)
Neural Portfolio Company Hanf.com Expands German Retail Footprint with New Muhldorf am Inn Store and Four Refurbished Locations

Toronto, Ontario--(Newsfile Corp. - May 19, 2026) - Neural Therapeutics Inc. (CSE: NURL) (FSE: HANF) ("Neural" or the "Company"), an ethnobotanical drug discovery company focused on developing therapeutic...

NURL.CN : 0.0150 (unch)
Upcoming Meeting Dates - February 16, 2026

Toronto, Ontario--(Newsfile Corp. - February 16, 2026) - The following is a list of Upcoming Meeting Dates announced this week for Reporting Issuers in Canada. The data is supplied by Issuing Companies...

ELY.VN : 0.100 (unch)
CVE.TO : 35.09 (-4.07%)
LME.VN : 0.185 (-5.13%)
AAUC.TO : 32.89 (-6.59%)
NOA.TO : 19.08 (-0.47%)
ACQ.TO : 22.26 (+0.86%)
SCR.TO : 38.53 (-7.25%)
EQX.TO : 13.31 (-4.11%)
LUN.TO : 32.84 (-5.41%)
MSP.VN : 0.325 (+18.18%)
RCH.TO : 39.31 (+1.08%)
GLAB.CN : 0.0300 (unch)
Upcoming Meeting Dates - January 12, 2026

Toronto, Ontario--(Newsfile Corp. - January 12, 2026) - The following is a list of Upcoming Meeting Dates announced this week for Reporting Issuers in Canada. The data is supplied by Issuing Companies...

MEQ.TO : 169.20 (-0.45%)
OLV.VN : 0.040 (unch)
TBRD.VN : 1.710 (+2.40%)
GOR.CN : 0.0200 (-20.00%)
GURU.TO : 3.85 (+4.90%)
ELL.VN : 0.080 (-5.88%)
TRAC.CN : 2.0000 (-0.99%)
BNS.TO : 121.48 (-0.96%)
GDI.TO : 36.57 (+0.05%)
NOAL.VN : 0.230 (-8.00%)
NERD.CN : 0.0300 (unch)
WBGD.CN : 0.4400 (+15.79%)
Upcoming Meeting Dates - December 8, 2025

Toronto, Ontario--(Newsfile Corp. - December 8, 2025) - The following is a list of Upcoming Meeting Dates for Reporting Issuers in Canada. The data is supplied by Issuing Companies through the service...

BBB.VN : 0.670 (-5.63%)
TUF.VN : 0.700 (+1.45%)
SPOD.CN : 0.0150 (+200.00%)
JTC.VN : 1.100 (unch)
SPC.VN : 0.080 (-5.88%)
TBRD.VN : 1.710 (+2.40%)
TM.VN : 0.400 (-2.44%)
VIZ.VN : 0.055 (-15.38%)
VRTX.CN : 0.4000 (-1.23%)
WBGD.CN : 0.4400 (+15.79%)
TRBR.VN : 1.640 (+0.61%)
VVC.VN : 0.010 (unch)
Neural's Partner CWE to Open Store No. 16 in the City of Bonn and Invitation to Meet Hanf.com at Mary Jane Berlin 2025

Toronto, Ontario--(Newsfile Corp. - June 6, 2025) - Neural Therapeutics Inc. (CSE: NURL) (FSE: HANF) ("Neural" or the "Company"), an ethnobotanical drug discovery company focused on developing therapeutic...

NURL.CN : 0.0150 (unch)
Neural Therapeutics and Hanf.com Sign Strategic Investment and Option Agreement to Create a Science-Backed Botanical Wellness Leader

Toronto, Ontario--(Newsfile Corp. - May 28, 2025) - Neural Therapeutics Inc. (CSE: NURL) (FSE: HANF) ("Neural" or the "Company"), an ethnobotanical drug discovery company focused on developing therapeutic...

NURL.CN : 0.0150 (unch)
Neural Therapeutics Announces RSU and Options Grant

Toronto, Ontario--(Newsfile Corp. - May 13, 2025) - Neural Therapeutics Inc. (CSE: NURL) (FSE: HANF) ("Neural" or the "Company"), an ethnobotanical drug discovery company focused on developing therapeutic...

NURL.CN : 0.0150 (unch)
Neural Therapeutics Announces SERFOR Permit Renewal Submission and Extension of LOI with HANF.COM

Toronto, Ontario--(Newsfile Corp. - May 9, 2025) - Neural Therapeutics Inc. (CSE: NURL) (FSE: HANF) ("Neural" or the "Company"), an ethnobotanical drug discovery company focused on developing therapeutic...

NURL.CN : 0.0150 (unch)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Sell with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Neural Therapeutics Inc is a wholly-owned subsidiary of High Fusion focused on ethnobotanical drug discovery and development company. Neural Therapeutics is focused on developing products and conducting research on the psychoactive cacti plants with the primary objective to find where the historical...

See More

Key Turning Points

3rd Resistance Point 0.0150
2nd Resistance Point 0.0150
1st Resistance Point 0.0150
Last Price 0.0150
1st Support Level 0.0150
2nd Support Level 0.0150
3rd Support Level 0.0150

See More

52-Week High 0.0350
Fibonacci 61.8% 0.0254
Fibonacci 50% 0.0225
Fibonacci 38.2% 0.0195
Last Price 0.0150
52-Week Low 0.0100

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.